- This event has passed.
AK Lecture 05: “IVF add-ons: Widespread use of unproven treatment options”
June 14 @ 5:00 pm - 6:00 pm EDT
Provided by: Mass General Brigham and MGH Center for Faculty Development
The Anne Klibanski Visiting Lecture Series was created to support and advance the careers of women. These lectures bring together faculty from institutions that have hosted Anne Klibanski Scholars with MGH scholars, on topics that overlap both research areas.
Upon completion of this activity, participants were able to:
• Understand the concept of ‘IVF add-ons ‘and the complexity of an IVF add-on definition
• Understand the evidence base for common add-ons
• Understand the views of patients and professionals about using or recommending add-ons
Target Audience: This activity is intended for faculty and faculty trainees.
Course Director: Miriam A. Bredella, MD
Presenter: Sarah Lensen, PhD, Research Fellow, Department of OB/GYN, The University of Melbourne, Australia
Dr. Lensen’s research broadly aims to improve and facilitate evidence-based healthcare of women. She has been involved in a number of large clinical trials evaluating infertility treatment options, including intrauterine insemination and endometrial scratching for IVF. She is an editor for the Cochrane Gynaecology and Fertility Group and has published many systematic reviews and meta-analyses. She also has a keen interest in clinical trial and research methodology. She was involved in an international process to establish a core outcome set for infertility trials, and a process to develop key priorities for research.
Her current research aims to understand why unproven treatments options are used in reproductive medicine, and to develop evidence-based resources to assist with informed decision making.
Mass General Brigham is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Mass General Brigham designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.